Penn State Hershey Medical Center research funding tops $100 million

July 26, 2005

Hershey, Pa. -- Research funding at Penn State College of Medicine, Penn State Milton S. Hershey Medical Center, hit an all-time high in the 2005 fiscal year (FY), exceeding $100 million.

This continues a growth trend in sponsored research funding, which started at $54 million in FY 2000, and increased to $70.1 million in 2001, $83.3 million in 2002, $85.1 million in 2003, $98.4 million in 2004, and now, $100.8 million in 2005.

"Exceeding our $100 million goal is an important milestone for our institution and is a true testament of the dedication, initiative and expertise of our talented faculty, scientists and staff," said Jay Moskowitz, associate vice president for health sciences research for Penn State, vice dean for research and graduate studies for Penn State College of Medicine, and chief scientific officer for Penn State Hershey Medical Center.

"Penn State's research mission plays a key part in the continued growth in our region's economic prosperity. Biomedical research is a great catalyst for the creation of skilled high level jobs and new products and services that benefit the health of all Americans."

During FY 2005, investigators submitted 904 proposals, requesting $164.8 million for sponsored programs, which include all grants and contracts supporting research, teaching and patient care, whether they be funded by the National Institutes of Health, other government agencies, private foundations or industry.

During the same period, investigators received 595 awards, totaling $100.8 million, an increase of 5.3 percent in the number of awards received and an increase of 2.3 percent in sponsored funding awarded compared to 2004.

Research funding is used to support programs and infrastructure like that at the Penn State General Clinical Research Center, and educational programs like the National Institutes of Health-funded K30 program, which supports the training of physicians in clinical research methods.

Funding is also used to support collaborative research projects like the work by Ian Zagon, Jill Smith and Patricia McLaughlin on the use of opioid growth factor to treat pancreatic cancer, a project that started in Zagon and McLaughlin's basic science laboratories and moved to clinical studies led by Smith. Other research projects involve cross-institution and industry partnerships.

"None of this would be possible without collaboration, cooperation and partnerships with our Penn State University colleagues, federal and state agencies, other colleges and universities, international scientists and more," Moskowitz said. "This intricate network only strengthens our collective quest for improvements in medical quality, increases our knowledge base and brings better care to patients more quickly."

Research funding proposals may take months to write and be based on years of preliminary data. Funding organizations may then take months to review proposals and even conduct on-site evaluations before deciding which proposals should be funded and for how much.

Penn State Hershey Medical Center offers support to investigators and program directors making proposals for research funding through its Offices of Research Affairs and Research Development.

"We've nearly doubled our research funding in just five years. Now we must set the bar even higher," Moskowitz said. "We must use this success to foster new partnerships, maximize available resources at University Park and other campuses, and continue making discoveries that improve our understanding of disease and how we can use this knowledge to improve quality of life of people in Pennsylvania and throughout our nation."

(Media Contacts)

Last Updated March 19, 2009